http://clinicaltrials.gov/ct2/show/NCT01499563This study is coming to a close in november and will result in march 2013 estimated.
this is a 5ht2a antagonist and dopamine phophomodulator. it also seems to have glutamatergic modulating action.
so basically much less sleepiness, but still more quaint sleepiness. plus less cognitive effection.
it was made in 2009, so they might of not caught on early enough but said they did.
either way if you wait it out 2 and a half more years you'll definetly be having a better time on the new meds.
nicotinic agonists/modulators (cognition)
glycine agonists/reuptake inhibitors (negative)
dopamine modulators (more ambitious for positives)
http://www.schizophreniaforum.org/res/d ... asp?type=&